Exact Sciences CorpEXAS
NasdaqCM•Healthcare•Diagnostics & Research
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $3.25B, growing 17.7% year-over-year. TTM net income stood at $-207.95M (79.8% growth). Quarterly EBITDA was $-26.24M and operating income was $-82.59M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze EXAS growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters